Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Eigenbrot

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Protein & Peptide Science|August 22, 2002
Structure, function, and activation of coagulation factor VIICharles Eigenbrot
Current Opinion in Chemical Biology|May 21, 2013
Two-in-One antibodies with dual action FabsCharles Eigenbrot, Germaine Fuh
Trends in Cardiovascular Medicine|February 14, 2002
New insight into how tissue factor allosterically regulates factor VIIaCharles Eigenbrot, Daniel Kirchhofer
The Biochemical Journal|August 14, 2010
Structural and mechanistic insight into how antibodies inhibit serine proteasesRajkumar Ganesan, Charles Eigenbrot, Daniel Kirchhofer
The FEBS Journal|April 21, 2010
Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1)Charles Eigenbrot, Rajkumar Ganesan, Daniel Kirchhofer
The Journal of Biological Chemistry|August 28, 2002
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitorJennifer Stamos, Mark X Sliwkowski, Charles Eigenbrot
The Journal of Biological Chemistry|March 27, 2003
Engineering exosite peptides for complete inhibition of factor VIIa using a protease switch with substrate phageHenry R Maun, Charles Eigenbrot, Robert A Lazarus
Protein Science : a Publication of the Protein Society|October 21, 2011
The ErbB4 extracellular region retains a tethered-like conformation in the absence of the tetherPing Liu, Samuel Bouyain, Charles Eigenbrot, et al.
Current Medicinal Chemistry|September 24, 2004
Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapyRobert A Lazarus, Alan G Olivero, Charles Eigenbrot, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Structural basis for high-affinity HER2 receptor binding by an engineered proteinCharles Eigenbrot, Mark Ultsch, Anatoly Dubnovitsky, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Protein & Peptide Science|August 22, 2002
Structure, function, and activation of coagulation factor VIICharles Eigenbrot
Current Opinion in Chemical Biology|May 21, 2013
Two-in-One antibodies with dual action FabsCharles Eigenbrot, Germaine Fuh
Trends in Cardiovascular Medicine|February 14, 2002
New insight into how tissue factor allosterically regulates factor VIIaCharles Eigenbrot, Daniel Kirchhofer
The Biochemical Journal|August 14, 2010
Structural and mechanistic insight into how antibodies inhibit serine proteasesRajkumar Ganesan, Charles Eigenbrot, Daniel Kirchhofer
The FEBS Journal|April 21, 2010
Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1)Charles Eigenbrot, Rajkumar Ganesan, Daniel Kirchhofer
The Journal of Biological Chemistry|August 28, 2002
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitorJennifer Stamos, Mark X Sliwkowski, Charles Eigenbrot
The Journal of Biological Chemistry|March 27, 2003
Engineering exosite peptides for complete inhibition of factor VIIa using a protease switch with substrate phageHenry R Maun, Charles Eigenbrot, Robert A Lazarus
Protein Science : a Publication of the Protein Society|October 21, 2011
The ErbB4 extracellular region retains a tethered-like conformation in the absence of the tetherPing Liu, Samuel Bouyain, Charles Eigenbrot, et al.
Current Medicinal Chemistry|September 24, 2004
Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapyRobert A Lazarus, Alan G Olivero, Charles Eigenbrot, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Structural basis for high-affinity HER2 receptor binding by an engineered proteinCharles Eigenbrot, Mark Ultsch, Anatoly Dubnovitsky, et al.
Pageof 11